BE898417A - Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone. - Google Patents

Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone. Download PDF

Info

Publication number
BE898417A
BE898417A BE0/212016A BE212016A BE898417A BE 898417 A BE898417 A BE 898417A BE 0/212016 A BE0/212016 A BE 0/212016A BE 212016 A BE212016 A BE 212016A BE 898417 A BE898417 A BE 898417A
Authority
BE
Belgium
Prior art keywords
sep
weight
hydrocortisone
solution
composition according
Prior art date
Application number
BE0/212016A
Other languages
English (en)
French (fr)
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BE898417A publication Critical patent/BE898417A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
BE0/212016A 1982-12-09 1983-12-08 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone. BE898417A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU84514A LU84514A1 (fr) 1982-12-09 1982-12-09 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone

Publications (1)

Publication Number Publication Date
BE898417A true BE898417A (fr) 1984-06-08

Family

ID=19729991

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212016A BE898417A (fr) 1982-12-09 1983-12-08 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone.

Country Status (7)

Country Link
JP (1) JPS59112921A (de)
BE (1) BE898417A (de)
CH (1) CH658191A5 (de)
DE (1) DE3344437A1 (de)
FR (1) FR2537438B1 (de)
GB (1) GB2131693B (de)
LU (1) LU84514A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
EP0978574A1 (de) * 1998-08-04 2000-02-09 Nalco Chemical Company Zusammensetzungen von kationische Tenside und deren Verwendung als verschmutzungsverhindernde Substanzen für Gebläse mit erzwungenen Abzug
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US10851507B2 (en) 2017-12-11 2020-12-01 Pro-Tech Manufacturing And Distribution, Inc. Material pusher with floating coupler

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE673500C (de) * 1933-01-15 1939-03-23 Hoffmann La Roche & Co Akt Ges Verfahren zur Herstellung von haltbaren Loesungen schwer loeslicher Arzneimittel
NL6610468A (de) * 1965-08-03 1967-02-06
FR2314731A1 (fr) * 1975-06-19 1977-01-14 Nelson Res & Dev Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning

Also Published As

Publication number Publication date
GB2131693A (en) 1984-06-27
CH658191A5 (fr) 1986-10-31
JPS59112921A (ja) 1984-06-29
FR2537438A1 (fr) 1984-06-15
JPH034044B2 (de) 1991-01-22
LU84514A1 (fr) 1984-10-22
DE3344437C2 (de) 1991-04-04
GB2131693B (en) 1986-07-02
FR2537438B1 (fr) 1985-11-22
DE3344437A1 (de) 1984-06-14
GB8332805D0 (en) 1984-01-18

Similar Documents

Publication Publication Date Title
CH657987A5 (fr) Composition anti-acneique a base de peroxyde de benzoyle et d'au moins un autre principe actif.
EP0680745B1 (de) Verwendung von antimykotischen Mitteln und von halogenierten antibakteriellen Mitteln zur Verringerung des Haarausfalls
EP0971687B1 (de) Wässrige lösungen von salicylsaure derivaten
CA2165613C (fr) Composition cosmetique, dermatologique ou pharmaceutique stable contenant du disulfure de selenium et au moins un sel de zinc
CH656532A5 (fr) Composition stable pour corticotherapie locale.
CA1302286C (fr) Composition cosmetique detergente et moussante, retardant le regraissage des cheveux
LU85111A1 (fr) Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire
FR2743813A1 (fr) Composition gelifiee stable a forte teneur en electrolyte
CA1341273C (fr) Systeme anti-oxydant a base d'un ester d'ascorbyle stabilise et compositions contenant un tel systeme anti-oxydant
FR2577805A1 (fr) Composition de traitement de la peau a base de glucoside d'hydroquinone
EP0841892A1 (de) Minoxidil enthaltendes haarpflegemittel mit einem niedrigen gehalt an fettigem lösungsmittel
WO2007132134A2 (fr) Compositions comprenant au moins un dérivé de l'acide naphtoïque et du péroxyde de benzoyle, leurs procédés de préparation, et leurs utilisations
EP0835652B1 (de) Verwendung von mindestens einem Glykol zur Solubilisierung von Melatonin in Wasser und sie enthaltende Zusammensetzungen
FR2783706A1 (fr) Composition aqueuse gelifiee stable a forte teneur en electrolyte
FR2490492A1 (fr) Composition cosmetique pour le traitement local de la cellulite
EP2114387B1 (de) Verwendung von zusammensetzungen mit mindestens einem lignan und/oder neolignan zur modulation der testosteron-spiegel
BE898417A (fr) Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone.
FR2855721A1 (fr) Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique
EP0243248A1 (de) Präparate zur Behandlung der Kahlheit und Alopezien
EP0751759B1 (de) Haarlotion enthaltend Minoxidil
FR2802096A1 (fr) Composition, notamment cosmetique, comprenant un acide triterpene pentacyclique
FR2857222A1 (fr) Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique
FR2543828A1 (fr) Nouvelle composition anti-acneique a base de tioxolone et d'au moins un autre principe actif
BE1000153A4 (fr) Composition anti-acneique stable a base d'erythromycine.
FR2569561A1 (fr) Composition stable d'anthraline dans des triglycerides d'acides gras satures d'origine vegetale ayant de 6 a 12 atomes de carbone

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. L OREAL

Effective date: 19921231